Logo image of SHO

SUNSTONE HOTEL INVESTORS INC (SHO) Stock Fundamental Analysis

NYSE:SHO - New York Stock Exchange, Inc. - US8678921011 - REIT - Currency: USD

8.84  +0.16 (+1.84%)

After market: 8.84 0 (0%)

Fundamental Rating

4

Taking everything into account, SHO scores 4 out of 10 in our fundamental rating. SHO was compared to 130 industry peers in the Diversified REITs industry. The financial health of SHO is average, but there are quite some concerns on its profitability. SHO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SHO had positive earnings in the past year.
SHO had a positive operating cash flow in the past year.
Of the past 5 years SHO 4 years were profitable.
Of the past 5 years SHO 4 years had a positive operating cash flow.
SHO Yearly Net Income VS EBIT VS OCF VS FCFSHO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.64%, SHO is in line with its industry, outperforming 50.77% of the companies in the same industry.
SHO has a Return On Equity (0.95%) which is in line with its industry peers.
With a Return On Invested Capital value of 2.09%, SHO is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for SHO is in line with the industry average of 3.16%.
Industry RankSector Rank
ROA 0.64%
ROE 0.95%
ROIC 2.09%
ROA(3y)3.11%
ROA(5y)-0.84%
ROE(3y)4.55%
ROE(5y)-1.22%
ROIC(3y)2.7%
ROIC(5y)N/A
SHO Yearly ROA, ROE, ROICSHO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 2.14%, SHO is in line with its industry, outperforming 45.38% of the companies in the same industry.
SHO's Profit Margin has declined in the last couple of years.
SHO has a Operating Margin of 8.43%. This is amonst the worse of the industry: SHO underperforms 82.31% of its industry peers.
SHO's Operating Margin has declined in the last couple of years.
The Gross Margin of SHO (60.93%) is worse than 66.92% of its industry peers.
SHO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.43%
PM (TTM) 2.14%
GM 60.93%
OM growth 3YN/A
OM growth 5Y-9.81%
PM growth 3Y4.77%
PM growth 5Y-22.47%
GM growth 3Y-0.55%
GM growth 5Y-0.8%
SHO Yearly Profit, Operating, Gross MarginsSHO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SHO is destroying value.
Compared to 1 year ago, SHO has less shares outstanding
SHO has less shares outstanding than it did 5 years ago.
The debt/assets ratio for SHO is higher compared to a year ago.
SHO Yearly Shares OutstandingSHO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SHO Yearly Total Debt VS Total AssetsSHO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

SHO has an Altman-Z score of 1.16. This is a bad value and indicates that SHO is not financially healthy and even has some risk of bankruptcy.
SHO has a better Altman-Z score (1.16) than 82.31% of its industry peers.
SHO has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SHO (0.41) is better than 93.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 1.16
ROIC/WACC0.24
WACC8.73%
SHO Yearly LT Debt VS Equity VS FCFSHO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.27 indicates that SHO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, SHO is in the better half of the industry, outperforming 63.08% of the companies in the same industry.
SHO has a Quick Ratio of 1.27. This is a normal value and indicates that SHO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.27, SHO is in the better half of the industry, outperforming 63.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
SHO Yearly Current Assets VS Current LiabilitesSHO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

The earnings per share for SHO have decreased strongly by -66.67% in the last year.
Measured over the past years, SHO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.38% on average per year.
The Revenue has decreased by -3.90% in the past year.
SHO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.07% yearly.
EPS 1Y (TTM)-66.67%
EPS 3Y29.76%
EPS 5Y-23.38%
EPS Q2Q%-80%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y21.17%
Revenue growth 5Y-4.07%
Sales Q2Q%7.78%

3.2 Future

Based on estimates for the next years, SHO will show a very strong growth in Earnings Per Share. The EPS will grow by 24.89% on average per year.
Based on estimates for the next years, SHO will show a small growth in Revenue. The Revenue will grow by 4.03% on average per year.
EPS Next Y-1.4%
EPS Next 2Y19.21%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year7.13%
Revenue Next 2Y5.28%
Revenue Next 3Y4.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SHO Yearly Revenue VS EstimatesSHO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SHO Yearly EPS VS EstimatesSHO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 88.40, SHO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of SHO is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.21, SHO is valued quite expensively.
A Price/Forward Earnings ratio of 44.43 indicates a quite expensive valuation of SHO.
Based on the Price/Forward Earnings ratio, SHO is valued a bit cheaper than 60.77% of the companies in the same industry.
SHO is valuated expensively when we compare the Price/Forward Earnings ratio to 21.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 88.4
Fwd PE 44.43
SHO Price Earnings VS Forward Price EarningsSHO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHO indicates a somewhat cheap valuation: SHO is cheaper than 66.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.29
SHO Per share dataSHO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as SHO's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.21%
EPS Next 3Y24.89%

4

5. Dividend

5.1 Amount

SHO has a Yearly Dividend Yield of 4.05%, which is a nice return.
SHO's Dividend Yield is slightly below the industry average, which is at 6.64.
SHO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 4.05%

5.2 History

The dividend of SHO decreases each year by -9.74%.
SHO has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SHO decreased in the last 3 years.
Dividend Growth(5Y)-9.74%
Div Incr Years2
Div Non Decr Years2
SHO Yearly Dividends per shareSHO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.5 1

5.3 Sustainability

427.55% of the earnings are spent on dividend by SHO. This is not a sustainable payout ratio.
DP427.55%
EPS Next 2Y19.21%
EPS Next 3Y24.89%
SHO Yearly Income VS Free CF VS DividendSHO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M
SHO Dividend Payout.SHO Dividend Payout, showing the Payout Ratio.SHO Dividend Payout.PayoutRetained Earnings

SUNSTONE HOTEL INVESTORS INC

NYSE:SHO (7/1/2025, 9:08:04 PM)

After market: 8.84 0 (0%)

8.84

+0.16 (+1.84%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners102.02%
Inst Owner Change0.4%
Ins Owners1.21%
Ins Owner Change6.39%
Market Cap1.76B
Analysts74.29
Price Target10.05 (13.69%)
Short Float %7.39%
Short Ratio5.2
Dividend
Industry RankSector Rank
Dividend Yield 4.05%
Yearly Dividend0.45
Dividend Growth(5Y)-9.74%
DP427.55%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.09)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.14%
Min EPS beat(2)28.25%
Max EPS beat(2)164.03%
EPS beat(4)3
Avg EPS beat(4)25.3%
Min EPS beat(4)-100%
Max EPS beat(4)164.03%
EPS beat(8)7
Avg EPS beat(8)358.09%
EPS beat(12)11
Avg EPS beat(12)329.11%
EPS beat(16)14
Avg EPS beat(16)252.57%
Revenue beat(2)1
Avg Revenue beat(2)-1.56%
Min Revenue beat(2)-3.82%
Max Revenue beat(2)0.7%
Revenue beat(4)1
Avg Revenue beat(4)-1.9%
Min Revenue beat(4)-3.82%
Max Revenue beat(4)0.7%
Revenue beat(8)4
Avg Revenue beat(8)-0.76%
Revenue beat(12)8
Avg Revenue beat(12)1.84%
Revenue beat(16)11
Avg Revenue beat(16)2.69%
PT rev (1m)-2.39%
PT rev (3m)-14.35%
EPS NQ rev (1m)2.17%
EPS NQ rev (3m)-24.93%
EPS NY rev (1m)29.55%
EPS NY rev (3m)-26.91%
Revenue NQ rev (1m)-0.94%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)-1.01%
Revenue NY rev (3m)-2.66%
Valuation
Industry RankSector Rank
PE 88.4
Fwd PE 44.43
P/S 1.91
P/FCF N/A
P/OCF 10.72
P/B 0.85
P/tB 0.85
EV/EBITDA 12.29
EPS(TTM)0.1
EY1.13%
EPS(NY)0.2
Fwd EY2.25%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)0.82
OCFY9.32%
SpS4.64
BVpS10.45
TBVpS10.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 0.95%
ROCE 2.65%
ROIC 2.09%
ROICexc 2.14%
ROICexgc 2.14%
OM 8.43%
PM (TTM) 2.14%
GM 60.93%
FCFM N/A
ROA(3y)3.11%
ROA(5y)-0.84%
ROE(3y)4.55%
ROE(5y)-1.22%
ROIC(3y)2.7%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.94%
ROICexgc(5y)N/A
ROCE(3y)3.42%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-13.98%
ROICexc growth 3YN/A
ROICexc growth 5Y-13.98%
OM growth 3YN/A
OM growth 5Y-9.81%
PM growth 3Y4.77%
PM growth 5Y-22.47%
GM growth 3Y-0.55%
GM growth 5Y-0.8%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 4.09
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.67
Cash Conversion 79.75%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 1.16
F-Score4
WACC8.73%
ROIC/WACC0.24
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3Y29.76%
EPS 5Y-23.38%
EPS Q2Q%-80%
EPS Next Y-1.4%
EPS Next 2Y19.21%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y21.17%
Revenue growth 5Y-4.07%
Sales Q2Q%7.78%
Revenue Next Year7.13%
Revenue Next 2Y5.28%
Revenue Next 3Y4.03%
Revenue Next 5YN/A
EBIT growth 1Y-30%
EBIT growth 3YN/A
EBIT growth 5Y-13.48%
EBIT Next Year209.81%
EBIT Next 3Y51.43%
EBIT Next 5YN/A
FCF growth 1Y-668.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.68%
OCF growth 3Y81.77%
OCF growth 5Y-10.15%